| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |